People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

8.70USD
6 Jul 2015
Change (% chg)

$0.12 (+1.40%)
Prev Close
$8.58
Open
$8.50
Day's High
$8.74
Day's Low
$8.36
Volume
1,705,580
Avg. Vol
3,286,480
52-wk High
$16.87
52-wk Low
$6.61

Search Stocks

Frashier, Gary 

Mr. Gary E. Frashier is an Independent Director of Achillion Pharmaceuticals, Inc., since March 2008. Mr. Frashier, through his company Management Associates, has been a strategic consultant to emerging growth companies in the life sciences field since 2000. From 1990 until 1998, he served as Chief Executive Officer of OSI Pharmaceuticals, Inc., a biotechnology company, and from 1997 until 2000, as its Chairman of the Board. From 1987 until 1990, he served as President and CEO of Genex Corporation, a protein engineering company, and from 1984 until 1987, as Chairman and CEO of Continental Water Systems, Inc., a manufacturer and marketer of equipment to produce ultra-high purity water used by the pharmaceutical, medical, electronics and research industries. Mr. Frashier also served as Executive Vice President of Millipore Corporation, a provider of products and services used in pharmaceuticals, manufacturing, clinical, analytical and research laboratories, and as President of Millipore’s Waters Associates chromatography subsidiary. Mr. Frashier also serves on the Board of Directors of privately held Metric Medical Devices, Inc, a medical device developer and marketing company, and Viroxis Corporation, a biopharmaceutical company. Mr. Frashier received a B.S. in Chemical Engineering from Texas Tech University, where he is a Distinguished Engineer, and received his M.B.A. from the Massachusetts Institute of Technology, where he was an Alfred P. Sloan Fellow.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Scheer

--

Milind Deshpande

4,947,740

Mary Fenton

1,723,720

David Apelian

2,493,280

Joseph Truitt

1,740,040

Michael Kishbauch

376,546
As Of  30 Dec 2014
Search Stocks